Heat Biologics Company Profile (NASDAQ:HTBX)

About Heat Biologics

Heat Biologics logoHeat Biologics, Inc. is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. It is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: HTBX
  • CUSIP:
Key Metrics:
  • Previous Close: $1.44
  • 50 Day Moving Average: $1.49
  • 200 Day Moving Average: $0.89
  • 52-Week Range: $19,491,000.00 - $0.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.22
  • P/E Growth: 0.00
  • Market Cap: $28.07M
  • Outstanding Shares: 19,491,000
  • Beta: 0.25
Profitability:
  • Return on Equity: -489.80%
  • Return on Assets: -155.97%
Debt:
  • Debt-to-Equity Ratio: 1.82%
  • Current Ratio: 1.61%
  • Quick Ratio: 1.61%
Additional Links:
Companies Related to Heat Biologics:

Analyst Ratings

Consensus Ratings for Heat Biologics (NASDAQ:HTBX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.92 (449.77% upside)

Analysts' Ratings History for Heat Biologics (NASDAQ:HTBX)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016Roth CapitalReiterated RatingBuy$2.75View Rating Details
8/17/2016Noble FinancialReiterated RatingBuy$8.00View Rating Details
4/9/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
2/21/2016HC WainwrightReiterated RatingBuy$13.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Heat Biologics (NASDAQ:HTBX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/28/2016        
8/15/2016Q2($0.27)($0.17)ViewN/AView Earnings Details
5/11/2016Q1($0.56)($0.50)ViewN/AView Earnings Details
2/18/2016Q4($0.64)($0.78)ViewN/AView Earnings Details
10/30/2015Q3($0.61)($0.62)ViewN/AView Earnings Details
8/13/2015Q2($0.47)($0.56)ViewN/AView Earnings Details
5/14/2015Q1($0.49)($0.57)ViewN/AView Earnings Details
4/16/2015($0.49)($0.56)ViewN/AView Earnings Details
3/27/2015($0.44)($0.56)ViewN/AView Earnings Details
11/14/2014Q314($0.42)($0.46)ViewN/AView Earnings Details
8/14/2014Q214($0.40)($0.44)ViewN/AView Earnings Details
5/14/2014($0.38)($0.36)ViewN/AView Earnings Details
4/1/2014($0.30)($0.55)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Heat Biologics (NASDAQ:HTBX)
Current Year EPS Consensus Estimate: $-0.76 EPS
Next Year EPS Consensus Estimate: $-0.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Heat Biologics (NASDAQ:HTBX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Heat Biologics (NASDAQ:HTBX)
Insider Ownership Percentage: 22.80%
Institutional Ownership Percentage: 8.63%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/23/2016Michael KharitonovDirectorBuy900,000$0.75$675,000.00View SEC Filing  
5/19/2014Jeffrey Alan WolfCEOBuy2,500$4.13$10,325.00View SEC Filing  
5/16/2014Paul BelskyDirectorBuy2,500$4.11$10,275.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Heat Biologics (NASDAQ:HTBX)
DateHeadline
News IconKeen Investors Find News on Heat Biologics, Inc. (NASDAQ:HTBX) - Duncan Research (NASDAQ:HTBX)
www.duncanindependent.com - September 23 at 5:09 PM
News IconCantor Fitzgerald Comments on Heat Biologics' FY2015 Earnings ... - Petro Global News 24 (NASDAQ:HTBX)
petroglobalnews24.com - September 22 at 8:38 AM
News IconPenny Stock Investors Take an Interest in Heat Biologics, Inc. (NASDAQ:HTBX) - Duncan Research (NASDAQ:HTBX)
www.duncanindependent.com - September 21 at 9:41 AM
News IconHeat Biologics Inc (NASDAQ:HTBX): Delving Into The Science Behind Its Latest Update (NASDAQ:HTBX)
streetregister.com - September 17 at 5:11 PM
News IconHeat Biologics Inc (NASDAQ:HTBX): Delving Into The Science Behind Its Latest Update - Street Register (NASDAQ:HTBX)
streetregister.com - September 17 at 10:06 AM
News IconHeat Biologics Inc. (NASDAQ: HTBX) Buy Rating Reiterated at Roth Capital - BNB Daily (blog) (NASDAQ:HTBX)
www.baseball-news-blog.com - September 16 at 5:22 PM
News IconHeat Biologics (HTBX) Receives Anayst Rating - National Daily Press (NASDAQ:HTBX)
www.nationaldailypress.com - September 16 at 9:24 AM
News IconHeat Biologics (HTBX) Receives Anayst Rating | National Daily Press - National Daily Press (NASDAQ:HTBX)
www.nationaldailypress.com - September 16 at 9:24 AM
News IconVolatile Measures on Top- Pernix Therapeutics (NASDAQ:PTX), Heat Biologics (NASDAQ:HTBX), Endeavour Silver ... - Seneca Globe (NASDAQ:HTBX)
www.senecaglobe.com - September 15 at 8:39 AM
smarteranalyst.com logoCompany Update (NASDAQ:HTBX): Heat Biologics Inc Resumes Enrollment in its Non-Small Cell Lung Cancer Trial ... - Smarter Analyst (NASDAQ:HTBX)
www.smarteranalyst.com - September 15 at 8:39 AM
News IconData will Enable Further Evaluation of the Potential of HS-110 to Convert Cold to Hot Tumors in NSCLC Patients (NASDAQ:HTBX)
www.pressreleasepoint.com - September 14 at 5:37 PM
streetinsider.com logoHeat Biologics (HTBX) Resumes Enrollment in NSCLC Lung Cancer Trial Evaluating HS-110 Combo (NASDAQ:HTBX)
www.streetinsider.com - September 14 at 9:44 AM
finance.yahoo.com logo7:01 am Heat Biologics resumes enrollment in its Phase 1b trial evaluating HS-110 in combination with nivolumab, a Bristol-Myers Squibb (BMY (NASDAQ:HTBX)
finance.yahoo.com - September 14 at 9:44 AM
publicnow.com logoHeat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Checkpoint Inhibitor (NASDAQ:HTBX)
www.publicnow.com - September 14 at 9:44 AM
publicnow.com logoHeat Biologics to Present at Two Upcoming Investor Conferences (NASDAQ:HTBX)
www.publicnow.com - September 13 at 10:16 AM
News IconShares Higher in Today's Session: Heat Biologics, Inc. (NASDAQ:HTBX) - Post News (NASDAQ:HTBX)
www.kentuckypostnews.com - September 8 at 5:25 PM
News IconIntraday Active Biotech Stocks News: Heat Biologics, Inc. (NASDAQ:HTBX), Illumina Inc. (NASDAQ:ILMN) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - September 6 at 10:14 AM
News IconHere’s What We’re Looking For When The Heat Biologics Inc (NASDAQ:HTBX) Data Hits (NASDAQ:HTBX)
streetregister.com - August 30 at 5:36 PM
News IconNews review of 2 biotech stocks: Heat Biologics (NASDAQ:HTBX), Amicus Therapeutics (NASDAQ:FOLD) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 29 at 5:23 PM
streetinsider.com logoCryoport (CYRX), Heat Biologics (HTBX), KCAS Commence Temperature Impact on Biomarkers Study - StreetInsider.com (NASDAQ:HTBX)
www.streetinsider.com - August 29 at 10:02 AM
News Icon2 Biotech Stocks News And Price Trends: Heat Biologics (NASDAQ:HTBX), Keryx Biopharmaceuticals (NASDAQ:KERX) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 25 at 10:32 AM
News IconHeat Biologics, Inc.'s (HTBX): Trendy Stock of Yesterday - Hot Stocks Point (NASDAQ:HTBX)
www.hotstockspoint.com - August 25 at 10:32 AM
finance.yahoo.com logoHEAT BIOLOGICS, INC. Financials (NASDAQ:HTBX)
finance.yahoo.com - August 24 at 5:25 PM
News IconBiotech news that matter for investors: Heat Biologics (NASDAQ:HTBX), Onconova Therapeutics (NASDAQ:ONTX) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 20 at 9:43 AM
News IconHeat Biologics, Inc.'s (HTBX): Buyers and Sellers Alert - Hot Stocks Point (NASDAQ:HTBX)
www.hotstockspoint.com - August 19 at 8:29 AM
biz.yahoo.com logoHEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events (NASDAQ:HTBX)
biz.yahoo.com - August 18 at 8:31 AM
streetinsider.com logoNoble Financial Sees Multiple Readouts for Heat Biologics (HTBX) by YE16; Maintains 'Buy' Rating (NASDAQ:HTBX)
www.streetinsider.com - August 17 at 5:43 PM
News IconUpbeat Stocks in Focus- Heat Biologics (NASDAQ:HTBX), Concho Resources (NYSE:CXO), Parsley Energy (NYSE:PE) - Seneca Globe (NASDAQ:HTBX)
www.senecaglobe.com - August 16 at 8:54 AM
biz.yahoo.com logoHEAT BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:HTBX)
biz.yahoo.com - August 15 at 5:46 PM
publicnow.com logoHeat Biologics Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:HTBX)
www.publicnow.com - August 15 at 5:46 PM
biz.yahoo.com logoHEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi (NASDAQ:HTBX)
biz.yahoo.com - August 15 at 5:46 PM
News IconStock in Limelight: Heat Biologics, Inc. (NASDAQ:HTBX) - Post Registrar (NASDAQ:HTBX)
postregistrar.com - August 11 at 5:46 PM
News IconNasdaq Index Barely Moves But Technicals Say It’s the Quiet Before the Storm (NASDAQ:HTBX)
www.economiccalendar.com - August 9 at 4:20 PM
News IconHeat Biologics Inc (NASDAQ:HTBX): Power of Chart, You Need To Time The Breakout To Make Big Money (NASDAQ:HTBX)
www.marketnewscall.com - August 9 at 4:20 PM
News IconHC Stocks in Top Row: Heat Biologics Inc (NASDAQ:HTBX) PDL BioPharma Inc (NASDAQ:PDLI) - share market updates (press release) (NASDAQ:HTBX)
sharemarketupdates.com - August 9 at 8:30 AM
News IconHot Healthcare Stocks: Agenus Inc. (NASDAQ:AGEN), Heat Biologics, Inc. (NASDAQ:HTBX) - TWN (NASDAQ:HTBX)
thewellesleysnews.com - August 9 at 8:30 AM
fortune.com logoThe Insider Activity Don't Lie: Heat Biologics, Inc. (NASDAQ:HTBX) - Review Fortune (NASDAQ:HTBX)
reviewfortune.com - August 8 at 5:43 PM
News IconTime To Put On The Watch List? - Heat Biologics, Inc. (NASDAQ:HTBX), Ocular Therapeutix, Inc. (NASDAQ:OCUL) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 8 at 10:12 AM
News IconHigh-Momentum Healthcare Stocks: PTC Therapeutics (NASDAQ:PTCT), Heat Biologics (NASDAQ:HTBX) - TWN (NASDAQ:HTBX)
thewellesleysnews.com - August 8 at 10:12 AM
News IconEquity Research Analyst's Stock Ratings: Heat Biologics, Inc ... - TWN (NASDAQ:HTBX)
thewellesleysnews.com - August 6 at 8:22 AM
News IconHeat Biologics Inc (NASDAQ:HTBX): That’s How We Made Quick 50% In Swing Trade (NASDAQ:HTBX)
www.marketnewscall.com - August 5 at 5:37 PM
streetupdates.com logoAnalyst's Overview of Two Stocks: Insulet Corporation (NASDAQ:PODD) , Heat Biologics, Inc. (NASDAQ:HTBX) - Street Updates (NASDAQ:HTBX)
www.streetupdates.com - August 5 at 8:26 AM
News IconIntraday Active Biotech Stocks News: Heat Biologics (NASDAQ:HTBX), Aratana Therapeutics (NASDAQ:PETX) - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 5 at 8:26 AM
fortune.com logoAnalysts: Heat Biologics, Inc. (NASDAQ:HTBX) stock is worth $5.38 - Review Fortune (NASDAQ:HTBX)
reviewfortune.com - August 5 at 8:26 AM
streetupdates.com logoAnalyst's Stocks Rating Activity: Heat Biologics, Inc. (NASDAQ:HTBX) , Aratana Therapeutics, Inc. (NASDAQ:PETX) - Street Updates (NASDAQ:HTBX)
www.streetupdates.com - August 4 at 8:29 AM
streetupdates.com logoAnalysts Watching Stocks Update: Heat Biologics, Inc. (NASDAQ:HTBX) , AngioDynamics, Inc. (NASDAQ:ANGO) - Street Updates (NASDAQ:HTBX)
www.streetupdates.com - August 3 at 8:42 AM
News IconBiotech Stocks Worth a Closer Look: Heat Biologics, Inc. (NASDAQ:HTBX), EPIRUS Biopharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:HTBX)
voiceregistrar.com - August 2 at 10:17 AM
News IconHeat Biologics Inc (NASDAQ:HTBX) About To Be Bought Out? - Street Register (NASDAQ:HTBX)
streetregister.com - August 2 at 10:17 AM
News IconHeat Biologics Inc (NASDAQ:HTBX) About To Be Bought Out? (NASDAQ:HTBX)
streetregister.com - August 1 at 5:24 PM
streetupdates.com logoTraders Focused Stocks: EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) , Heat Biologics, Inc. (NASDAQ:HTBX) - Street Updates (NASDAQ:HTBX)
www.streetupdates.com - July 27 at 8:18 AM

Social

Heat Biologics (NASDAQ:HTBX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff